Clinical-stage psychedelic biotech, Tryp Therapeutics, Inc., has announced that its previously announced plan to merge with Exopharm Limited has received approval from Exopharm’s shareholders. The arrangement, which is expected to close on or about May 1, has satisfied all conditions precedent, with the exception of the conditional approval from the …
Category: Psychedelics
The Daily Hit: April 23, 2024
The Daily Hit is a recap of the top financial news stories for Tuesday, April 23, 2024. On the Site Trulieve settles former worker’s wrongful termination lawsuit The case also alleged that the cannabis company ignored safety and sexual harassment complaints. Read more here. ‘Don’t flood the market:’ Fault lines …
Hypha Labs pivots to psilocybin with new mushroom tech
Hypha Labs Inc. (OTC: DIGP), formerly known as Digipath, announced its transition from the cannabis industry to the emerging market of functional mushrooms, with a particular focus on psilocybin. The company said it has developed a patent-pending bioreactor technology that aims to streamline the production of active ingredients found in …
DEA resists permitting psilocybin for terminal patients under ‘Right to Try’
A long-running showdown between a doctor and the U.S. Drug Enforcement Administration that could affect the legal status of psychedelics is heating up. The agency last week urged the Ninth Circuit Court of Appeal to block the physician’s efforts to use psilocybin to treat depression in terminally ill cancer patients, …